TELA Bio (TELA) Preferred Dividend Payments (2018 - 2019)
TELA Bio (TELA) recorded quarterly Preferred Dividend Payments of $940000.0 in Q4 2019, down 54.32% quarter-over-quarter from $2.1 million in Q3 2019, and down 52.41% on a YoY basis from $2.0 million in Q4 2018.
TELA Bio (TELA) Preferred Dividend Payments (2018 - 2019) Analysis & Trends
TELA Bio's Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $940000.0 for Q4 2019.
- In Q4 2019, Preferred Dividend Payments fell 52.41% year-over-year to $940000.0; the TTM figure through Dec 2019 stood at $7.8 million (changed N/A YoY), while the FY2019 annual figure was $7.8 million, down 11.79% from the prior year.
- Preferred Dividend Payments was $940000.0 for Q4 2019 at TELA Bio, down from $2.1 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $2.8 million in Q2 2019 to a low of $940000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | TELA Bio | 48.23 Mn | 8.69 Mn | 12.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 940,000.00 |
| Sep 30, 2019 | 2.06 Mn |
| Jun 30, 2019 | 2.76 Mn |
| Mar 31, 2019 | 2.03 Mn |
| Dec 31, 2018 | 1.98 Mn |
| Sep 30, 2018 | 1.87 Mn |